Form 4: Thermo Fisher Scientific Director James C. Mullen Reports Transaction
SEC Form 4 Filing
Director James C. Mullen reports acquisition and disposal of Thermo Fisher Scientific common stock.
Summary
- On May 21, 2025, James C. Mullen, a director of Thermo Fisher Scientific, reported a transaction involving the company's common stock.
- Mullen acquired 565 shares of common stock.
- Mullen disposed of 3,393 shares of common stock.
- Following the reported transactions, Mullen beneficially owns 3,393 shares of Thermo Fisher Scientific.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of transaction involving Thermo Fisher Scientific common stock. |
| 05/22/2025 | Date of signature by Attorney-in-Fact for James C. Mullen. |
Keywords
Form 4, Thermo Fisher Scientific, TMO, Director, James C. Mullen, Stock Transaction, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.